This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Gemini Therapeutics Future Growth
Future criteria checks 0/6
Key information
20.9%
Earnings growth rate
34.8%
EPS growth rate
| Biotechs earnings growth | 20.8% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | n/a |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2024 | N/A | -14 | -12 | N/A | 1 |
| 12/31/2023 | N/A | -14 | -12 | N/A | 1 |
| 12/31/2022 | N/A | -14 | -12 | N/A | 1 |
| 9/30/2022 | N/A | -43 | -43 | -43 | N/A |
| 6/30/2022 | N/A | -59 | -55 | -55 | N/A |
| 3/31/2022 | N/A | -68 | -61 | -61 | N/A |
| 12/31/2021 | N/A | -72 | -60 | -60 | N/A |
| 9/30/2021 | N/A | -68 | -56 | -56 | N/A |
| 6/30/2021 | N/A | -60 | -47 | -47 | N/A |
| 3/31/2021 | N/A | -50 | -38 | -38 | N/A |
| 12/31/2020 | N/A | -41 | -33 | -33 | N/A |
| 9/30/2020 | N/A | -36 | -35 | -35 | N/A |
| 6/30/2020 | N/A | -37 | -37 | -37 | N/A |
| 3/31/2020 | N/A | -41 | -39 | -39 | N/A |
| 12/31/2019 | N/A | -41 | -39 | -39 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GMTX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: GMTX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: GMTX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if GMTX's revenue is forecast to grow faster than the US market.
High Growth Revenue: GMTX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GMTX's Return on Equity is forecast to be high in 3 years time